Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS2359 in adult ADHD
NCT00467428Phase 2Completed
- Sponsor
- NeuroSearch
- Start
- Aug 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NS2359 in attention deficit hyperactivity disorder (ADHD), sponsored by NeuroSearch. Started Aug 2003; status: completed.
02
Drugs
NS2359
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00467428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467428.